{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T08:31:12Z","timestamp":1790411472098,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T00:00:00Z","timestamp":1706140800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T00:00:00Z","timestamp":1706140800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Professor David Moore"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Neurological infection is an important cause of critical illness, yet little is known on the epidemiology of neurological infections requiring critical care.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We analysed data on all adults with proven or probable neurological infection admitted to UK (NHS) critical care units between 2001 and 2020 reported to the Intensive Care National Audit and Research Centre. Diagnoses, physiological variables, organ support and clinical outcomes were analysed over the whole period, and for consecutive 5-year intervals within it. Predictors of in-hospital mortality were identified using a backward stepwise regression model.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We identified 20,178 critical care admissions for neurological infection. Encephalitis was the most frequent presentation to critical care, comprising 6725 (33.3%) of 20,178 cases. Meningitis\u2013 bacterial, viral or unspecified cases - accounted for 10,056 (49.8%) of cases. In-hospital mortality was high, at 3945\/19,765 (20.0%) overall. Over the four consecutive 5-year periods, there were trends towards higher Glasgow Coma Scale scores on admission, longer critical care admissions (from median 4 [IQR 2\u20138] to 5 days [IQR 2\u201310]), and reduced in-hospital mortality (from 24.9 to 18.1%). We identified 12 independent predictors of in-hospital death which when used together showed good discrimination between patients who die and those who survive (AUC\u2009=\u20090.79).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Admissions with neurological infection to UK critical care services are increasing and the mortality, although improving, remains high. To further improve outcomes from severe neurological infection, novel approaches to the evaluation of risk stratification, monitoring and management strategies are required.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-024-08976-z","type":"journal-article","created":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T11:03:43Z","timestamp":1706180623000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["A retrospective analysis of 20,178 adult neurological infection admissions to United Kingdom critical care units from 2001 to 2020"],"prefix":"10.1186","volume":"24","author":[{"given":"Joseph","family":"Donovan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abena","family":"Glover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Gregson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew W.","family":"Hitchings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma C.","family":"Wall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert S.","family":"Heyderman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,25]]},"reference":[{"key":"8976_CR1","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/S1474-4422(18)30387-9","volume":"17","author":"JR Zunt","year":"2018","unstructured":"Zunt JR, Kassebaum NJ, Blake N, et al. Global, regional, and national burden of meningitis, 1990\u20132016: a systematic analysis for the global burden of Disease Study 2016. Lancet Neurol. 2018;17:1061.","journal-title":"Lancet Neurol"},{"key":"8976_CR2","unstructured":"World Health Organization. Geneva. Defeating meningitis by 2030 global road map (version 26 October 2020). https:\/\/www.who.int\/publications\/m\/item\/defeating-meningtis-by-2030-global-road-map-(version-20-october-2020) (accessed July 16, 2021)."},{"key":"8976_CR3","first-page":"1122","volume":"66","author":"E Pasquier","year":"2018","unstructured":"Pasquier E, Kunda J, de Beaudrap P, et al. Long-term mortality and disability in cryptococcal meningitis: a systematic literature review. Clin Infect Dis. 2018;66:1122\u201332.","journal-title":"Clin Infect Dis"},{"key":"8976_CR4","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nrneurol.2017.120","volume":"13","author":"RJ Wilkinson","year":"2017","unstructured":"Wilkinson RJ, Rohlwink U, Misra UK, et al. Tuberculous meningitis. Nat Rev Neurol. 2017;13:581\u201398.","journal-title":"Nat Rev Neurol"},{"key":"8976_CR5","doi-asserted-by":"crossref","unstructured":"Dyckhoff-Shen S, Koedel U, Pfister H-W, Klein M. SOP: emergency workup in patients with suspected acute bacterial meningitis. Neurological Research and Practice 2021 3:1 2021; 3: 1\u20137.","DOI":"10.1186\/s42466-020-00098-6"},{"key":"8976_CR6","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/S1474-4422(19)30154-1","volume":"18","author":"J Donovan","year":"2019","unstructured":"Donovan J, Figaji A, Imran D, Phu NH, Rohlwink U, Thwaites GE. The neurocritical care of tuberculous meningitis. Lancet Neurol. 2019;18:771\u201383.","journal-title":"Lancet Neurol"},{"key":"8976_CR7","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.jinf.2016.01.007","volume":"72","author":"F McGill","year":"2016","unstructured":"McGill F, Heyderman RS, Michael BD, et al. The UK joint specialist societies guideline on the diagnosis and management of acute meningitis and meningococcal sepsis in immunocompetent adults. J Infect. 2016;72:405\u201338.","journal-title":"J Infect"},{"key":"8976_CR8","doi-asserted-by":"crossref","unstructured":"Vengamma B, Rajguru M, Prasad BCM, Ramesh Chandra VV. Central nervous system infections in the intensive care unit. J Clin Sci Res 2014;: 106\u201313.","DOI":"10.15380\/2277-5706.JCSR.13.044"},{"key":"8976_CR9","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1056\/NEJMra052116","volume":"354","author":"D van de Beek","year":"2006","unstructured":"van de Beek D, de Gans J, Tunkel AR, Wijdicks EFM. Community-acquired bacterial meningitis in adults. N Engl J Med. 2006;354:44\u201353.","journal-title":"N Engl J Med"},{"key":"8976_CR10","doi-asserted-by":"publisher","unstructured":"Brouwer MC, Mcintyre P, Prasad K, van de Beek D. Corticosteroids for acute bacterial meningitis. Cochrane Database of Systematic Reviews. 2015;CD004405. https:\/\/doi.org\/10.1002\/14651858.CD004405.pub5.","DOI":"10.1002\/14651858.CD004405.pub5"},{"key":"8976_CR11","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1056\/NEJMoa040573","volume":"351","author":"GE Thwaites","year":"2004","unstructured":"Thwaites GE, Bang ND, Dung NH, et al. Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. N Engl J Med. 2004;351:1741\u201351.","journal-title":"N Engl J Med"},{"key":"8976_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002244.pub4","author":"K Prasad","year":"2016","unstructured":"Prasad K, Singh MB, Ryan H. Corticosteroids for managing tuberculous meningitis. Cochrane Database of Systematic Reviews. 2016. https:\/\/doi.org\/10.1002\/14651858.CD002244.pub4. Published online April 28.","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"8976_CR13","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1056\/NEJMoa1509024","volume":"374","author":"J Beardsley","year":"2016","unstructured":"Beardsley J, Wolbers M, Kibengo FM, et al. Adjunctive dexamethasone in HIV-Associated Cryptococcal Meningitis. N Engl J Med. 2016;374:542\u201354.","journal-title":"N Engl J Med"},{"key":"8976_CR14","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1086\/380970","volume":"38","author":"P Lindvall","year":"2004","unstructured":"Lindvall P, Ahlm C, Ericsson M, Gothefors L, Naredi S, Koskinen L-OD. Reducing intracranial pressure may increase survival among patients with bacterial meningitis. Clin Infect Dis. 2004;38:384\u201390.","journal-title":"Clin Infect Dis"},{"key":"8976_CR15","doi-asserted-by":"publisher","first-page":"e91976","DOI":"10.1371\/journal.pone.0091976","volume":"9","author":"M Glim\u00e5ker","year":"2014","unstructured":"Glim\u00e5ker M, Johansson B, Halldorsdottir H, et al. Neuro-intensive treatment targeting intracranial hypertension improves outcome in severe bacterial meningitis: an intervention-control study. PLoS ONE. 2014;9:e91976.","journal-title":"PLoS ONE"},{"key":"8976_CR16","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1001\/jama.2020.2717","volume":"323","author":"JL Vincent","year":"2020","unstructured":"Vincent JL, Sakr Y, Singer M, et al. Prevalence and outcomes of infection among patients in Intensive Care Units in 2017. JAMA. 2020;323:1478.","journal-title":"JAMA"},{"key":"8976_CR17","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.jcrc.2013.12.001","volume":"29","author":"D Fernandes","year":"2014","unstructured":"Fernandes D, Gon\u00e7alves-Pereira J, Janeiro S, Silvestre J, Bento L, P\u00f3voa P. Acute bacterial meningitis in the intensive care unit and risk factors for adverse clinical outcomes: retrospective study. J Crit Care. 2014;29:347\u201350.","journal-title":"J Crit Care"},{"key":"8976_CR18","doi-asserted-by":"publisher","first-page":"61","DOI":"10.4266\/acc.2021.01151","volume":"37","author":"SR Valdoleiros","year":"2022","unstructured":"Valdoleiros SR, Torr\u00e3o C, Freitas LS, Mano D, Gon\u00e7alves C, Teixeira C. Nosocomial meningitis in intensive care: a 10-year retrospective study and literature review. Acute and Critical care. 2022;37:61\u201370.","journal-title":"Acute and Critical care"},{"key":"8976_CR19","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s00134-023-07032-9","volume":"49","author":"R Sonneville","year":"2023","unstructured":"Sonneville R, de Montmollin E, Contou D, et al. Clinical features, etiologies, and outcomes in adult patients with meningoencephalitis requiring intensive care (EURECA): an international prospective multicenter cohort study. Intensive Care Med. 2023;49:517\u201329.","journal-title":"Intensive Care Med"},{"key":"8976_CR20","doi-asserted-by":"publisher","first-page":"e062698","DOI":"10.1136\/bmjopen-2022-062698","volume":"12","author":"J Ellis","year":"2022","unstructured":"Ellis J, Harvey D, Defres S, et al. Clinical management of community-acquired meningitis in adults in the UK and Ireland in 2017: a retrospective cohort study on behalf of the National Infection Trainees Collaborative for Audit and Research (NITCAR). BMJ Open. 2022;12:e062698.","journal-title":"BMJ Open"},{"key":"8976_CR21","unstructured":"Intensive Care National Audit & Research Centre. Home. 2022. https:\/\/www.icnarc.org\/ (accessed Dec 13, 2022)."},{"key":"8976_CR22","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1097\/01.CCM.0000259468.24532.44","volume":"35","author":"DA Harrison","year":"2007","unstructured":"Harrison DA, Parry GJ, Carpenter JR, Short A, Rowan K. A new risk prediction model for critical care: the Intensive Care National Audit & Research Centre (ICNARC) model. Crit Care Med. 2007;35:1091\u20138.","journal-title":"Crit Care Med"},{"key":"8976_CR23","unstructured":"Intensive Care Society. Levels of care. 2021. https:\/\/ics.ac.uk\/resource\/levels-of-care.html (accessed Feb 7, 2023)."},{"key":"8976_CR24","doi-asserted-by":"publisher","unstructured":"Capuzzo M, Volta CA, Tassinati T, et al. Hospital mortality of adults admitted to Intensive Care Units in hospitals with and without Intermediate Care units: a multicentre European cohort study. Crit Care. 2014;18. https:\/\/doi.org\/10.1186\/S13054-014-0551-8.","DOI":"10.1186\/S13054-014-0551-8"},{"key":"8976_CR25","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S1474-4422(18)30499-X","volume":"18","author":"VL Feigin","year":"2019","unstructured":"Feigin VL, Nichols E, Alam T, et al. Global, regional, and national burden of neurological disorders, 1990\u20132016: a systematic analysis for the global burden of Disease Study 2016. Lancet Neurol. 2019;18:459.","journal-title":"Lancet Neurol"},{"key":"8976_CR26","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.3201\/eid2709.204866","volume":"27","author":"S Subbarao","year":"2021","unstructured":"Subbarao S, Campbell H, Ribeiro S, et al. Invasive meningococcal Disease, 2011\u20132020, and impact of the COVID-19 pandemic, England. Emerg Infect Dis. 2021;27:2495.","journal-title":"Emerg Infect Dis"},{"key":"8976_CR27","unstructured":"Our World in Data. Intensive care beds per 100,000 people., 2020. 2020. https:\/\/ourworldindata.org\/grapher\/intensive-care-beds-per-100000 (accessed Feb 9, 2023)."},{"key":"8976_CR28","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.jinf.2014.05.012","volume":"69","author":"S Kadambari","year":"2014","unstructured":"Kadambari S, Okike I, Ribeiro S, et al. Seven-fold increase in viral meningo-encephalitis reports in England and Wales during 2004\u20132013. J Infect. 2014;69:326\u201332.","journal-title":"J Infect"},{"key":"8976_CR29","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/S1473-3099(18)30245-7","volume":"18","author":"F McGill","year":"2018","unstructured":"McGill F, Griffiths MJ, Bonnett LJ, et al. Incidence, aetiology, and sequelae of viral meningitis in UK adults: a multicentre prospective observational cohort study. Lancet Infect Dis. 2018;18:992\u20131003.","journal-title":"Lancet Infect Dis"},{"key":"8976_CR30","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.3201\/eid1909.130064","volume":"19","author":"J Granerod","year":"2013","unstructured":"Granerod J, Cousens S, Davies NWS, Crowcroft NS, Thomas SL. New estimates of incidence of Encephalitis in England. Emerg Infect Dis. 2013;19:1455.","journal-title":"Emerg Infect Dis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-024-08976-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-024-08976-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-024-08976-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T11:04:46Z","timestamp":1706180686000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-024-08976-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,25]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["8976"],"URL":"https:\/\/doi.org\/10.1186\/s12879-024-08976-z","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,25]]},"assertion":[{"value":"26 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in accordance with relevant guidelines and regulations, and in accordance with the Declaration of Helsinki.ICNARC data were collected by ICNARC under existing ethical approvals. As available on , ICNARC have approval to hold patient identifiable data under Sect.\u00a0251 of the NHS Act 2006. Approval was granted by the Confidentiality Advisory Group (CAG) within the Health Research Authority (HRA) (previously National Information Governance Board). The approval number for the CMP was PIAG 2\u201310(f)\/2005. Ethical approval for this study was granted by the London School of Hygiene and Tropical Medicine Research Ethics Committee (26550). Individual participant content was waived by the London School of Hygiene and Tropical Medicine Research Ethics Committee due to retrospective nature of the study. An information sharing agreement was signed with ICNARC.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"132"}}